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Summary
The eIF4E-binding proteins (4E-BPs) repress translation initiation by preventing eIF4F complex
formation. Of the three mammalian 4E-BPs, only 4E-BP2 is enriched in the mammalian brain and
plays an important role in synaptic plasticity and learning and memory formation. Here we describe
asparagine deamidation as brain-specific posttranslational modification of 4E-BP2. Deamidation is
the spontaneous conversion of asparagines to aspartates. Two deamidation sites were mapped to an
asparagine-rich sequence unique to 4E-BP2. Deamidated 4E-BP2 exhibits increased binding to the
mammalian Target of Rapamycin (mTOR)-binding protein raptor, which effects its reduced
association with eIF4E. 4E-BP2 deamidation occurs during postnatal development, concomitant with
the attenuation of the activity of the PI3K-Akt-mTOR signalling pathway. Expression of deamidated
4E-BP2 in 4E-BP2−/− neurons yielded mEPSCs exhibiting increased charge transfer with slower
rise and decay kinetics, relative to the wild type form. 4E-BP2 deamidation may represent a
compensatory mechanism for the developmental reduction of PI3K-Akt-mTOR signalling.
© 2009 Elsevier Inc. All rights reserved.
Correspondence: nahum.sonenberg@mcgill.ca.
8Present Address: Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA
*These authors contributed equally to this work.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting
proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could
affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Mol Cell. Author manuscript; available in PMC 2010 September 26.
Published in final edited form as:
Mol Cell. 2010 March 26; 37(6): 797–808. doi:10.1016/j.molcel.2010.02.022.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Introduction
Eukaryotic protein synthesis is primarily controlled at the initiation phase. A critical early event
in this process is the association of the eukaryotic initiation factor 4E (eIF4E) with the mRNA
5′ m7GpppN-cap structure. eIF4E associates with eIF4G and eIF4A, to form the three-subunit
eIF4F complex, which facilitates 40S ribosome recruitment to the mRNA 5′ end (Gingras et
al., 1999b; Pestova et al., 2007). In mammals, an important regulatory function in this process
is carried out by the eIF4E-binding proteins. The members of this family of three paralogs (4E-
BP1, 2, and 3) compete with eIF4G for the same binding site on the dorsal surface of eIF4E
(Mader et al., 1995; Marcotrigiano et al., 1999), and thereby inhibit translation initiation by
preventing the interaction of eIF4E with eIF4G (Haghighat et al., 1995). The association of
the 4E-BPs with eIF4E is abrogated by their hierarchical, multi-site phosphorylation (Gingras
et al., 2001a; Mothe-Satney et al., 2000). The 4E-BPs exhibit disparate tissue expression (Lin
and Lawrence 1996; Tsukiyama-Kohara et al. 2001). 4E-BP2 is predominant in the brain and
its requirement for learning and memory has been studied extensively. Deletion of 4E-BP2 in
mice engenders hippocampus-dependent memory impairments and alterations in long-lasting
forms of synaptic plasticity (Banko et al., 2006; Banko et al., 2007; Banko et al., 2005).
The eIF4E-binding activity of the 4E-BPs is regulated through phosphorylation by the
mammalian target of rapamycin complex 1 (mTORC1) (Gingras et al., 2001b; Proud, 2009;
Yonezawa et al., 2004). In addition to the large serine/threonine kinase mTOR, this complex
consists of GβL (LST8), and the mTORC1-defining member, raptor. Raptor, is a large
scaffolding protein that recruits mTORC1 substrates to the mTOR kinase domain through
interaction with a substrate-specific TOR signaling (TOS) motif (Ma and Blenis, 2009). In 4E-
BPs, the C-terminal TOS motif is necessary for binding to raptor and, consequently, for
phosphorylation leading to their release from eIF4E (Nojima et al., 2003; Schalm et al.,
2003). However, recent studies have indicated that the TOS motif alone is insufficient for
efficacious 4E-BP1-raptor binding, thereby suggesting that other sequences in the 4E-BPs
enhance this interaction (Choi et al., 2003; Eguchi et al., 2006; Lee et al., 2008).
mTOR stimulates cell growth and proliferation (Sarbassov et al., 2005). mTOR integrates
inputs from several signaling cascades communicating extracellular stimuli (PI3K-Akt
pathway), intracellular energy status (LKB1-AMPK), cellular stresses (virus infection and
hypoxia), and nutrient availability (Rag GTPases) into growth-promoting outputs, in particular
protein synthesis (Sancak and Sabatini, 2009; Wullschleger et al., 2006). In neuronal systems,
mTOR modulates several processes, including learning and memory (Ehninger et al., 2008;
Parsons et al., 2006), synaptic plasticity (Cammalleri et al., 2003; Tang et al., 2002), dendritic
protein synthesis (Gobert et al., 2008; Takei et al., 2004; Tsokas et al., 2005), and formation
of the dendrite arbor (Jaworski et al., 2005; Kumar et al., 2005). However, recent work
demonstrated that mTORC1 activity declines during postnatal development in retinal ganglion
neurons (Park et al., 2008).
Here we describe a brain-specific posttranslational modification of 4E-BP2. In the mammalian
brain two C-terminal asparagines were found to undergo developmentally regulated
deamidation to aspartates. This resulted in enhanced association with raptor and reduced
translational repression. Expression of the deamidated form of 4E-BP2 in neurons altered the
time course of excitatory synaptic activity. We suggest that 4E-BP2 deamidation may act as a
compensatory mechanism to promote translation despite attenuated PI3K-Akt- mTOR
signalling in neuron development.
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Results
4E-BP2 in Mammalian Brain Resolves into Three Forms Independent of Phosphorylation
4E-BP2 from murine brain migrates in SDS-PAGE as three forms (Banko et al., 2005;
Tsukiyama-Kohara et al., 2001) that are reminiscent of the multi-site phosphorylated species
of 4E-BP1 (Gingras et al., 1999a; Lin et al., 1994). Considering the role of 4E-BP2 in synaptic
plasticity and learning and memory processes (Banko et al., 2006; Banko et al., 2007; Banko
et al., 2005), we wished to study its regulation by phosphorylation in the mammalian nervous
system. We first determined whether the hierarchical mode of 4E-BP1 phosphorylation, in
which Thr37 and Thr46 phosphorylation precedes Thr70 and Ser65, is maintained in 4E-BP2.
This was confirmed as 4E-BP2 Thr37Ala or Thr46Ala variants exhibited impaired
hyperphosphorylation, relative to Thr70Ala or wild type proteins (Figure S1). Surprisingly,
we were unable to detect significant levels of phosphorylated 4E-BP2 in adult whole brain or
hippocampal extracts by Western blotting (Figures 1A and S1). Moreover, the slowest-
migrating form is specific to the brain. If the migration pattern of brain-derived 4E-BP2 is due
to hyperphosphorylation one might expect reduced or abolished association with eIF4E, as is
the case for hyperphosphorylated 4E-BP1. However, Far Western (FW) blotting with
radiolabeled eIF4E on the brain lysates of wild type and 4E-BP2 null mice revealed that eIF4E
bound similarly to each of the three 4E-BP2 species (Figure 1B). Further, phosphatase
treatment of brain extract failed to alter the pattern of 4E-BP2 migration (Figure 1C). Thus,
these slow-migrating forms are not due to hyperphosphorylation
Asparagine Deamidation Causes the Slow Migrating Forms of 4E-BP2 in the Brain
No alternatively spliced 4E-BP2 transcripts have been identified; therefore, the possibility that
an uncharacterized posttranslational modification accounts for the slow-migrating 4E-BP2
forms in the brain was probable. To identify this modification, endogenous 4E-BP2 was
purified from adult murine brains and mass spectrometry was performed. This analysis detected
deamidation, the non-enzymatic conversion of asparagine to aspartate, near the C-terminus
(Figure S2). The deamidation process is largely influenced by the identity of the adjacent C-
terminal residue (Robinson et al., 1973; Robinson and Robinson, 2001) and the proximity to
flexible peptide regions (Xie and Schowen, 1999). The rate of deamidation is also increased
under alkaline conditions, thus facilitating analysis of susceptible residues (Robinson and
Rudd, 1974). Purified recombinant 4E-BP2 was therefore treated over a range of alkalinity.
Incubation for six hours elicited a single, slower migrating form, while an additional species
was noticed upon protracted incubation at higher pH (Figure 2A). Bcl-XL also exhibits reduced
electrophoretic mobility upon aspargine deamidation (Deverman et al. 2002). To confirm that
deamidation is the 4E-BP2 modification found in the brain, mouse embryonic fibroblasts
(MEFs) were starved of serum and amino acids to minimize phosphorylation, and cell lysates
were then subjected to alkaline conditions. A 4E-BP2 migration pattern, similar to that
described above (Figure 2A), was observed following alkaline treatment (Figure 2B), and was
identical to that of brain lysates in both SDS-PAGE (Figure S2) and IEF/SDS-PAGE (Figure
2C; second and third panels). Strikingly, the 4E-BP2 IEF/SDS-PAGE spots were perfectly
superimposed when the MEF and brain lysates were mixed, thereby confirming uniform
modification (Figure 2C; fourth panel). Thus, 4E-BP2 in the brain is modified by asparagine
deamidation.
Asparagines 99 and 102 are the Sites of 4E-BP2 Deamidation
We questioned whether asparagine deamidation is unique, amongst the 4E-BPs, to 4E-BP2.
4E-BP2 contains six closely-spaced asparagines near its C-terminus that are not conserved in
4E-BP1 (Figure 3A). Incubation of MEF lysates at alkaline pH caused a partial reduction in
4E-BP2 migration that was not observed for 4E-BP1 (Figure 3B). As deamidation appears to
be unique to 4E-BP2, we next sought to identify the modified sites. First, 3HA-tagged wild
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type 4E-BP2 and a variant lacking the asparagine-rich sequence (Δ87-104) were expressed in
HEK293 cells and subjected to alkaline treatment. The deletion variant exhibited no reduction
in electrophoretic mobility following incubation at pH 10, confirming that 4E-BP2 deamidation
occurs at this region (Figure 3C; note that the 3HA-tagged proteins do not migrate in a pattern
similar to endogenous 4E-BP2).
IEF/SDS-PAGE analysis of 4E-BP2 revealed two deamidated forms in the adult brain (Figure
2C). We therefore determined the major deamidation sites within the asparagine-rich stretch.
To do so, recombinant 4E-BP2 was treated at high pH and the resolved species (Figure 3D;
left panel) were analyzed by mass spectrometry. Because deamidation is non-enzymatic and
an intrinsic property of an asparagine within a peptide, the susceptible residues determined in
this analysis correspond to those occurring in vivo. A clear preference for aspartate formation
was observed at positions 99 and 102 (Figures 3D and S3). Mutating both of these residues to
alanines (N99A/N102A) confirmed this finding as it prevented the alkaline-induced
deamidation shift (Figure 3E). Asparagines 99 and 102 were then mutated to aspartates to
replicate in vivo deamidation. Electrophoretic mobility was reduced to a similar extent by the
N99D and N102D variants and even more so by N99D/N102D (Figure 3F), the form unique
to the brain.
Deamidated 4E-BP2 Exhibits Enhanced Raptor-Binding and Reduced eIF4E-Association
We considered the possibility that the proximity of the deamidation sites to the C-terminal
TOR signaling (TOS) motif might affect the interaction of 4E-BP2 with raptor. This is plausible
in light of recent findings that the TOS motif in 4E-BP1 alone can not account for efficient
raptor-binding (Lee et al., 2008). After co-transfection, more deamidated (N99D/N102D) 4E-
BP2 co-immunoprecipitated with raptor in comparison to wild type or 4E-BP2 N99A/N102A
(Figure 4A). Deletion of the TOS motif from 4E-BP2 (ΔTOS) abolished its interaction with
raptor. We then wondered whether 4E-BP2 deamidation affects its in vivo interaction with
eIF4E. Deamidated 4E-BP2 exhibited reduced association with eIF4E recovered on an mRNA
cap-analogue (m7GDP) resin (Figure 4B). As 4E-BP2 phosphorylation was not detected in
mature brain, the association of 4E-BP2 and eIF4E was monitored in conditions favouring
diminished 4E-BP2 phosphorylation owing to reduced mTORC1-activation. In the absence of
serum (-FBS) alone or of serum and nutrients (PBS) together, a marked reduction in eIF4E-
bound deamidated 4E-BP2 was still observed (Figures 4C and 4D). This effect was dependent
on interaction with raptor as deamidated 4E-BP2 lacking the TOS motif (N99D/N102D/ΔTOS)
displayed a greater or equal association with eIF4E relative to wild type 4E-BP2 (Figure 4D).
These findings were confirmed in vivo in the brain; comparison of the ratio of deamidated 4E-
BP2 to unmodified 4E-BP2 between m7GDP pulldowns and brain lysates indicated that more
unmodified 4E-BP2 (fastest migrating form) was recovered with eIF4E than were the
deamidated forms (Figure 4E). In agreement with these findings, prior work showed that
mutation of the TOS motif enhanced 4E-BP1 association with eIF4E (Schalm et al., 2003;
Wang et al., 2006). We also confirmed that the association of deamidated 4E-BP2 with raptor
increased under conditions of reduced mTORC1 activity (Figure S4). Far Western analysis on
brain lysates (Figure 1C) or recombinant proteins (Figure 4F) yielded similar eIF4E-binding
to wild type or deamidated 4E-BP2. However, as these assays involve the direct interaction
between eIF4E and non-phosphorylated 4E-BP2 in the absence of raptor, the results are
consistent with the above finding that the weakened association of deamidated 4E-BP2 with
eIF4E is effected by raptor.
We then tested the capacity of deamidated 4E-BP2 to repress translation. To do so, we first
used a luciferase reporter mRNA harbouring a 4E-BP-sensitive 5′ untranslated region (5′UTR),
which contains extensive secondary structure (ΔG = −137kCal/mol), obtained from the mRNA
of IRF-7 (Interferon Regulatory Factor 7) (Colina et al., 2008). In MEFs lacking 4E-BP1 and
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4E-BP2, expression of deamidated 4E-BP2 repressed translation of the reporter mRNA weakly
in comparison to wild type 4E-BP2 (Figure 4G). Importantly, the control luciferase mRNA
that contains weak secondary structure was not significantly inhibited by either deamidated or
wild type 4E-BP2 (Figure S4). We similarly observed in 4E-BP2−/− cultured neurons that
deamidated 4E-BP2 weakly repressed, relative to wild type 4E-BP2, the translation of a
previously characterized fluorescence-based reporter mRNA (Figure 4H). This mRNA
contains significant secondary structure in the 5′UTR (ΔG = −55kCal/mol), which is derived
from CaMKIIα mRNA. Translational expression from this reporter has been shown to be
induced by activity and is normally weak in dendrites distal to the cell body in unstimulated
conditions (Aakalu et al., 2001; Gong et al., 2006). Thus, our basal level measurements were
restricted to a proximal dendrite region (15-30μm from the cell body). Anisomycin treatment
confirmed that translation represents a significant component of expression from this reporter
mRNA in our assay. Overall, these experiments suggest that deamidated 4E-BP2 is a weak
repressor of translation by virtue of its enhanced association with raptor.
Developmental Reduction in PI3K-Akt-mTOR Signaling is Associated with the Onset of 4E-
BP2 Deamidation
The absence of phosphorylated 4E-BP2 in the mature brain is at variance with reports of robust
4E-BP phosphorylation in ex vivo dissociated neuron cultures (Kelleher et al., 2004; Takei et
al., 2001). These cultures are normally prepared from embryonic or early postnatal brains;
therefore, a developmental regulation of 4E-BP2 phosphorylation was considered. 4E-BP2
phosphorylation sharply receded during the first two weeks of postnatal brain development
[postnatal days (P) 3, 7 and 15; Figure 5A]. Concomitantly, the slow migrating deamidated
forms of 4E-BP2 became apparent with time. IEF/SDS-PAGE analysis of the P3 lysate
confirmed the stoichiometric abundance of phosphorylated 4E-BP2 species (horizontal
pattern) (Figure 5B). However, between one and three postnatal weeks, 4E-BP2
phosphorylation decreased, while the appearance of the deamidated forms (diagonal pattern)
became apparent (Figure 5C). Phosphatase treatment of the P15 lysate abolished the horizontal
pattern (Figure 5D), thereby confirming its assignment as multiple phosphorylation events.
Alkaline treatment of the P3 lysate induced the appearance of the doubly deamidated (N99D/
N102D) form that is normally present in the adult (Figure S5).
We next asked whether the PI3K-Akt-mTOR signaling module was affected during
development. Brain lysates from P3 and adult mice were examined along with lysates from
dissociated hippocampal neuron cultures at several days following plating (days in vitro; DIV).
The phosphorylation of both Akt and ribosomal protein S6 (rpS6), a downstream target of
mTORC1, were dramatically reduced in the adult brain relative to P3. This effect was mirrored
in cultured neurons between days 9 and 31 (Figure 5E). Diminished rpS6 phosphorylation was
also observed recently during development of retinal ganglion neurons (Park et al., 2008).
Importantly, 4E-BP2 deamidation was also observed in the cultured preparations (Figure 5E;
top panel). These observations, together with the raptor-dependent reduction of eIF4E-binding
(Figures 4C and 4D) and weak translation repression (Figures 4G and 4H), suggest the
possibility of a compensatory function for 4E-BP2 deamidation to permit protein synthesis
despite reduced, translation-promoting upstream signaling. In support of this putative function,
we found that the eIF4F complex, which is formed between eIF4E and eIF4G during translation
initiation and is antagonized by 4E-BPs, remained effectively associated during the
developmental period in which 4E-BP2 deamidation occurs (Figure 5F). Accordingly,
deamidated 4E-BP2 was weakly associated with eIF4E (Figure 5F).
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Expression of Deamidated 4E-BP2 in 4E-BP2−/− Neurons Alters the Kinetics of Excitatory
Synaptic Transmission
4E-BP2 knock-out mice display altered hippocampal long-term synaptic plasticity (Banko et
al. 2005, 2006). We therefore wondered whether 4E-BP2 deamidation impacts excitatory
postsynaptic transmission. To pursue this, AMPA receptor-mediated miniature excitatory
postsynaptic currents (mEPSCs) were recorded at the soma of CA1 pyramidal neurons in
organotypic slice cultures. These phenomena represent the postsynaptic current produced by
the presynaptic release of single glutamate vesicles. As a rule, mEPSC amplitude largely
reflects the number of AMPA receptors in the postsynaptic membrane, frequency depends on
both the probability of presynaptic transmitter release and the number of active synapses, while
charge transfer is the cumulative ion flow through open receptor channels (Lisman et al.,
2007). First, mEPSCs were compared between wild type and 4E-BP2−/− slices. 4E-BP2−/−
neurons exhibited approximately a two-fold increase in mEPSC amplitude, frequency, and
charge transfer relative to wild type controls (Figure 6A). The increases in amplitude and charge
transfer were not due to differences in cell cable properties or recording quality, because series
and input resistance and cell capacitance were not different between wild type and 4E-BP2−/
− neurons (Figure S6). Thus, excitatory synaptic activity is increased in the absence of 4E-
BP2. Next, wild type or deamidated 4E-BP2 (N99D/N102D) proteins were expressed in 4E-
BP2−/− neurons to examine their specific functions. mEPSC amplitude and frequency were
similarly repressed by expression of either protein (Figure 6B). However, mEPSC charge
transfer was only partially rescued by 4E-BP2 N99D/N102D. This incomplete repression
suggests that deamidated 4E-BP2 has an altered effect on mEPSC kinetics. Indeed, upon
expression of deamidated 4E-BP2, mEPSPs exhibited strikingly slower rise and decay times
in comparison to control (Figure 6C). No alterations in cable properties or experimental
recording were observed, and mEPSCs parameters from all groups were similarly correlated
with series resistance, input resistance and cell capacitance (Figure S6) (Spruston et al.,
1993). A role for 4E-BP2 deamidation is thus implied in the timing of excitatory postsynaptic
signals independently of its effect on synaptic strength. Possible mechanistic explanations for
this finding are addressed below.
Discussion
We present here the characterization of a developmentally patterned posttranslational
modification of 4E-BP2 in the brain. Deamidation of two asparagines in 4E-BP2 enhances its
binding to mTORC1 and reduces the kinetics of synaptic transmission. The genetic encoding
of asparagines that are susceptible to deamidation appears to be selected for and may act as a
‘molecular clock’ to regulate important biological events (Robinson and Robinson, 1991;
Robinson and Robinson, 2001). Therefore, the fact that the C-terminal, deamidation sequence
is perfectly conserved in 4E-BP2 in mammals but not in lower organisms, many of which
possess only a single 4E-BP gene (Figure S6), suggests a genetically-controlled link to
regulation of higher brain function.
The interaction of deamidated 4E-BP2 with raptor is enhanced relative to the wild type form.
Altered protein-protein interactions have also been demonstrated to be a consequence of
deamidation of Bcl-XL and fibronectin (Curnis et al., 2006; Deverman et al., 2002). 4E-BP2
deamidation therefore appears to have an auxiliary function in the TOS-dependent binding of
4E-BP2 to raptor. This is consistent with recent findings of an insufficiency of the 4E-BP1
TOS motif for efficient raptor-binding (Lee et al., 2008). Moreover, this finding suggests that
negative charges in the C-terminal region of 4E-BPs, possibly including non-conserved
phosphorylation sites in 4E-BP1 (Wang et al., 2003), may enhance this interaction.
Deamidated 4E-BP2 displays reduced affinity for eIF4E, a phenomenon which persists in
conditions of impaired mTORC1 activity and is dependent on interaction with raptor.
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Moreover, deamidated 4E-BP2 exhibited weak translational repression toward two reporter
mRNAs that contain significant 5′UTR secondary structure (Figures 4G and 4H). In agreement
with this, alterations in eIF4E levels selectively affect the translation of mRNAs with extensive
secondary structure in the 5′ untranslated leader sequence (De Benedetti and Graff, 2004; Graff
et al., 2007; Koromilas et al., 1992; Richter and Sonenberg, 2005). As 4E-BPs control the
availability eIF4E for eIF4F complex formation, the impact of 4E-BP2 deamidation on
translation may be limited to specific mRNAs harbouring structured 5′UTRs, as opposed to
bulk mRNAs. Furthermore, our findings suggest that a function of 4E-BP2 deamidation may
be to compensate for impaired upstream signalling that normally effects its phosphorylation.
Our observation that the eIF4F complex displays remarkable stability despite dramatic
reduction in mTORC1 activity during early brain development (Figure 5F) is consistent with
this notion.
How might the interaction of deamidated 4E-BP2 with raptor lead to reduced binding to eIF4E?
It is possible that raptor spatially sequesters 4E-BP2 away from eIF4E. This is conceivable in
light of previous reports demonstrating 4E-BP-dependent nuclear accumulation of eIF4E upon
inhibition of mTORC1 (Rong et al., 2008), and raptor-dependent perinuclear localization of
mTOR following release from amino-acid deprivation (Sancak et al., 2008). Thus, putative
partitioning of 4E-BP2 between eIF4E and raptor may favour interaction and co-localization
with raptor at the expense of eIF4E upon deamidation. In neurons, such an effect could occur
locally in dendrites as opposed to the cell body. It is also possible that enhanced
phosphorylation of deamidated 4E-BP2 may occur at activated dendritic synapses, consistent
with the previous detection by immunofluorescence of 4E-BP2 in dendritic puncta (Tang et
al., 2002) and DHPG-induced 4E-BP2 phosphorylation (T37/T46) in the stratum radiatum
(Banko et al., 2006). Yet, our inability to detect phosphorylated 4E-BP2 in the adult brain
suggests that such local phosphorylation may be largely diluted in whole cell lysates.
Pyramidal 4E-BP2−/− neurons displayed enhancement in mEPSC amplitude, frequency, and
charge transfer. Since the expression of wild type or deamidated 4E-BP2 in post-synaptic 4E-
BP2−/− neurons abolished the increase in amplitude and frequency, predominantly post-
synaptic changes, such as surface AMPA receptor expression, likely mediate these changes
(Malinow and Malenka, 2002). In contrast, charge transfer was only partially repressed by
expression of deamidated 4E-BP2 in 4E-BP2−/− neurons. Consistent with this finding, a salient
feature of our electrophysiological analysis is that mEPSCs in neurons expressing deamidated
4E-BP2 exhibit slower rise and decay times, relative to controls. This could favour enhanced
signal integration and, thus, plasticity. Importantly, mEPSCs have also been shown to influence
neuronal firing, synaptic restructuring, and activation of postsynaptic signaling cascades
(Carter and Regehr, 2002; McKinney et al., 1999; Murphy et al., 1994; Sharma and
Vijayaraghavan, 2003).
How might deamidated 4E-BP2 influence mEPSC kinetics? One possibility is based on cable
theory, which posits that the magnitude and kinetics of currents originating from distal synapses
become attenuated to a greater extent, while approaching the cell body, than those more
proximal to the soma (Bekkers and Stevens, 1996; Williams and Johnston, 1991). However,
AMPA receptor-mediated mEPSC amplitudes are relatively independent of synapse location
(Magee and Cook, 2000). Thus, deamidated 4E-BP2 might favour currents emanating from
distal dendritic regions, whereas such spatial selectivity would not be expected with expression
of the wild type protein. Indeed, we observed a near absence (< 5%) of fast mEPSCs upon
expression of deamidated 4E-BP2. This is consistent with an efficient and selective repression
of synaptic activity at synapses located proximally, whereas distally located “de-repressed”
synapses remain intact. This would account for mEPSCs exhibiting slower kinetics. An
alternative explanation is that the slower kinetics resulted from changes in cell cable properties
or recording quality (Spruston et al., 1993). However this appears unlikely since series
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resistance, input resistance and cell capacitance did not differ between neurons in all groups
(Figure S6), thus suggesting that the slower kinetics arise from direct effects on mEPSCs. A
third potential interpretation is that AMPA receptor channel gating is protracted. This could
be due to alterations in the subunit composition of the tetrameric AMPA receptors (Jonas,
2000) or the relative expression of AMPAR-associated auxiliary proteins (Milstein and Nicoll,
2008), both of which are known to influence postsynaptic current kinetics. In particular,
transmembrane AMPA receptor regulatory proteins (TARPs) (Milstein and Nicoll, 2008) and
cornichons (Schwenk et al., 2009) interact with AMPA receptors and slow gating kinetics and
increase charge transfer. However, TARPs tend to regulate decay kinetics and have only a
small influence on rise times. Indeed, in small cerebellar granule cells, the affect of TARPs on
activation kinetics (~0.5 ms) were less than those observed here (~1.5-2.0 ms) (Milstein et al.,
2007). Thus, in large pyramidal neurons the rise times of mEPSCs are filtered by the cable
properties of the neuron and do not reflect AMPA receptor gating kinetics. The observed effect
on decay kinetics, however, were in the range (7 – 12 ms) of those observed by TARP
modulation (Milstein et al., 2007) and are likely less affected by cable properties. Despite the
above possibilities, the mechanism responsible for deamidated 4E-BP2-dependent slow
mEPSCs and its importance for evoked synaptic transmission is presently unclear.
Recent work reported that mEPSCs block local dendritic translation to provide a rapid response
to postsynaptic activity. Increased protein synthesis and synaptic efficacy homeostatically
compensate for tonic inhibition of action potentials that is coupled to mEPSC blockade (Sutton
et al., 2006; Sutton et al., 2007; Sutton et al., 2004). In acute measurements (30 minutes)
however, we find larger and more frequent mEPSCs in the absence of a translation inhibitor,
a context which engenders enhanced synaptic transmission (Figure 6A). The initial reports
demonstrating a role for 4E-BP2 in synaptic plasticity found no change in basal synaptic
function upon genetic deletion of 4E-BP2 in mice (Banko et al., 2006; Banko et al., 2005). Our
finding of enhanced mEPSCs in 4E-BP2−/− organotypic slices is not at variance with this
conclusion as our results are based on non-evoked spontaneous quantal events, whereas the
observations of Banko et al. were induced by synaptic network stimulation. Thus, we have
revealed a unique modification of 4E-BP2 in the brain and a function for it in synaptic activity.
Experimental Procedures
Cell Culture, Transfections, Alkaline and Phosphatase Treatments
For transfection of HEK293 or HEK293E cells, 1 million cells/well were seeded in six-well
culture plates and 24 hours later were transfected for 3-5 hours using Lipofectamine/Plus
reagents (Invitrogen). Cells were harvested 24 hours post-transfection. Alkaline treatments on
cell extracts were performed as previously described (Deverman et al., 2002). Alkalinization
of recombinant 4E-BP2 protein was at 37°C in 0.15M Tris-HCl, pH 7.0 or 10.0. For
phosphatase treatments, tissues were homogenized in 1X λ phosphatase buffer containing 0.5
μg/mL leupetin and 1mM PMSF. Lysates (90μl) were incubated with 9μl of λ phosphatase at
30°C for 45 minutes.
Far Western Assay
Flag-HMK-eIF4E probe labelling, purification and Far Western blotting has been described
elsewhere (Gingras et al., 1996; Pause et al., 1994).
Immunoprecipitation and m7GDP Pull-down
For immunoprecipitation, lysates (200μg) were mixed with Myc antibody for 1.5 hours at 4°
C, followed by 1 hour incubation with 25μl of Protein G Sepharose (GE Healthcare). For
m7GDP pull-downs, lysates were mixed with 30μl of m7GDP-agarose for 1.5 hours at 4°C. In
either case, the resins were washed 4 times and proteins were eluted with 2X sample buffer.
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Mass Spectrometry Analysis of In Vitro Deamidated Recombinant 4E-BP2
Analysis of resolved 4E-BP2 species, obtained from alkaline treatment, was with a
ThermoFinnigan LTQ-Orbitrap hybrid mass spectrometer. Searches were conducted using X!
Tandem, with comparison to the IPI human database. Spectra corresponding to the peptide
VEVNNLNNLNNHDR were manually inspected for the proper assignment of the deamidated
species.
Luciferase Assays
Co-transfection of MEFs with reporter plasmids and analysis of luciferase activity was
performed as previously described (Colina et al., 2008). Free energies of formation of mRNA
secondary structures were predicted with Mfold (Zuker, 2003). Differences between group
means obtained from independent experiments were considered significant at p < 0.05 by
Student’s t-test.
Primary Neuron Culture, Transfection, Image Analysis
Hippocampal neuron cultures were prepared as previously described (Goslin et al., 1988).Ten
days after plating, neurons were co-transfected with 2μg of 4E-BP2 expression plasmid and
1.5μg of 5′myrdYFP3′ reporter plasmid using Lipofectamine 2000 (Invitrogen) and returned to
conditioned medium. Two days later cells were fixed and processed for immunofluorescence
using 4E-BP2 antibody (Cell Signaling), as described elsewhere (Lebeau et al., 2008). Images
of co-transfected neurons were acquired on an Olympus FV300 confocal microscope using a
40X PlanFluor 0.75 numerical aperture objective. Analysis of dYFP fluorescence from z-
compressed stacks was with Image J (NIH). Mean fluorescence for each group was reported
and statistical significance was determined by Student’s t-test.
Organotypic hippocampal slice cultures, transfections, and electrophysiology
Hippocampal slice cultures were prepared and biolistically transfected as previously described
(Bourdeau et al., 2007; Lebeau et al., 2008; Ran et al., 2009). Whole cell recordings were
obtained from transfected CA1 pyramidal neurons (Lebeau et al., 2008) in submerged slice
culture conditions (Ran et al., 2009) and mEPSC recording acquisition and analysis were
performed with pClamp9 software (Molecular Devices) as previously described (Ran et al.,
2009). mEPSC parameters were compared between groups using Kolmogorov-Smirnov tests.
A one-way ANOVA and Bonferroni post-hoc tests were used to compare passive membrane
properties. Data represent means ± SEM, unless otherwise mentioned, and statistical
significance was set at p < 0.05.
Highlights
• 4E-BP2 undergoes asparagine deamidation uniquely in the brain
• 4E-BP2 deamidation enhances its association with raptor and reduces eIF4E-
binding
• 4E-BP2 deamidation is developmentally regulated
• Deamidated 4E-BP2 slows excitatory Schaffer collateral synaptic transmission
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Slow-migrating forms of 4E-BP2 in the adult brain are independent of phosphorylation
(A) Reduced phosphorylation and a slow-migrating 4E-BP2 form are unique to the brain.
Mouse tissue lysates (3 months) were analyzed by Western blotting (15% SDS-PAGE). (B)
Far Western binding of eIF4E to 4E-BP2 from brain. Brain lysates were resolved and probed
on a nitrocellulose membrane with radiolabeled FLAG-HMK-eIF4E protein. Recombinant 4E-
BP1 and a variant lacking the eIF4E-binding site (Δ51-63) control for probe specificity.
Western blotting was with antibody #11211. (C) 4E-BP2 from mouse brain is insensitive to
phosphatase treatment. Brain lysates were incubated with λ phosphatase followed by Western
blotting. phospho-Thr-Pro motif antibody demonstrates phosphatase efficacy (lower panel).
See also Figure S1.
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Figure 2. 4E-BP2 is susceptible to asparagine deamidation in the mammalian brain
(A) Deamidation of recombinant 4E-BP2 at high pH. Recombinant 4E-BP2 was incubated in
0.15M Tris-HCl at the indicated pH and times, followed by Western blotting. Arrow heads
indicate deamidated forms of 4E-BP2. (B) Deamidation of 4E-BP2 in cell lysates. MEFs were
starved of serum for 24 hours, followed by one hour in PBS. Cells were lysed at the indicated
pH and extracts were incubated for 18 hours. (C) 4E-BP2 deamidation caused by alkaline
treatment or occurring spontaneously in hippocampus exhibits identical migration pattern in
two-dimensional isoelectric focusing/SDS-PAGE (IEF/SDS-PAGE). Alkaline-treated MEF or
untreated hippocampal lysates were analysed (panels 1-3). In panel 4, a 1:1 mixture of pH 10-
treated MEF and hippocampal lysates was analysed. See also Figure S2.
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Figure 3. Deamidation of 4E-BP2 occurs on asparagines 99 and 102
(A) Amino acid sequence alignment of murine 4E-BP2 and 4E-BP1. Inset shows the
asparagine-rich sequence of 4E-BP2. (B) 4E-BP2 is sensitive to alkaline-induced deamidation.
MEFs were lysed and incubated as in (Figure 2B). (C) A 4E-BP2 variant lacking the asparagine-
rich sequence is resistant to deamidation. HEK293E cells were transfected with N-terminal
3HA-tagged 4E-BP2 or a variant lacking residues 87-104. Post-transfection (24 hours) cells
were lysed at pH 7 or 10 and incubated as indicated. (D) Asn99 and Asn102 are favoured for
deamidation. Purified, recombinant 4E-BP2 protein was in vitro deamidated at pH 10 for 24h,
resolved by SDS-PAGE (10-20%), and stained (left panel). Excised bands were analysed by
LC-MS/MS (right). (E) Mutation of both Asn99 and Asn102 to alanines precludes alkaline-
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induced deamidation. HEK293E cells were transfected and treated as in (C). (F) Mutation of
Asn99 and Asn102 to aspartates retards 4E-BP2 migration. Cells were transfected as in (E).
See also Figure S3.
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Figure 4. Deamidated 4E-BP2 exhibits increased raptor-interaction, reduced association to eIF4E
and attenuated translational repression
(A) Deamidated 4E-BP2 exhibits enhanced affinity for raptor. HEK293 cells were co-
transfected with Myc-tagged raptor and 3HA-tagged 4E-BP2. Anti-Myc immunoprecipitation
was performed on lysates 24 hours later, followed by Western blotting (7-15% SDS-PAGE).
(B) Deamidated 4E-BP2 is weakly associated to eIF4E in cells grown in complete medium.
Lysates were incubated with m7GDP agarose and bound proteins were analyzed by Western
blotting. (C and D) Deamidated 4E-BP2 is more weakly associated to eIF4E in the absence of
serum or nutrients. Cells were starved of serum for 24 hours (C) or incubated in D-PBS for 1
hour (D) followed by m7GDP pulldown. (E) m7GDP pulldowns from brain lysates were
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performed as in (B). (F) Deamidation of 4E-BP2 does not affect eIF4E-binding in the absence
of raptor. Far Western blotting was performed as in Figure 1C against recombinant proteins.
(G and H) Deamidated 4E-BP2 weakly inhibits translation. 4E-BP1/4E-BP2 null MEFs were
co-transfected with 4E-BP2 together with IRF7-Firefly Luciferase and Renilla luciferase
plasmids (G) or cultured neurons were co-transfected with 4E-BP2 plasmids and a reporter
encoding myrdYFP flanked by the 5′ and 3′ UTRs of CamKIIα. MEFs in (G) were harvested
24 hours post-transfection and luciferase activity was measured (data are means ± SEM, with
statistical significance set at p < 0.05). Cultured neurons in (H) were transfected 10 days after
plating and two days later images of YFP-expressing neurons were acquired (N=9-12 cells;
bars represent means ± SEM and in all cases, except amongst anisomycin treatments, means
are different at p < 0.05 by Student’s t-test). 4E-BP2 expression was determined by
immunofluorescence and no differences between wild type and deamidated 4E-BP2 expression
was observed in proximal dendrites (not shown). See also Figure S4.
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Figure 5. Deamidation of 4E-BP2 occurs during early postnatal brain development, concomitant
with reduced PI3K-Akt-mTOR signaling
(A) Western blot analysis on hippocampal extracts (30μg each) from several postnatal (P) days
compared with adult. (B) IEF/SDS-PAGE analysis of P3 hippocampal extract. (C) IEF/SDS-
PAGE analysis of hippocampal extracts from indicated postnatal days. (D) Phosphatase
treatment of P15 hippocampal extract. (E) SDS-PAGE analysis of lysates from dissociated
hippocampal neuron cultures or brain from indicated days. (F) Analysis of associated eIF4E-
binding proteins during hippocampal neuron development by m7GDP precipitation. See also
Figure S5.
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Figure 6. Expression of deamidated 4E-BP2 in 4E-BP2−/− neurons reduces elevated excitatory
synaptic transmission but slows kinetics of mEPSCs
(A) Increased excitatory miniature synaptic activity in slices from 4E-BP2−/− mice. Left:
Traces of mEPSCs from 4EBP2−/− and wild type mice. Right: Cumulative probability plots
and summary bar graph for all cells showing increases in mEPSC amplitude, charge and
frequency. (N=6 neurons/genotype and 200 events/neuron; data are means ± SEM. p < 0.05.
Kolmogorov-Smirnov test). (B) Expression of deamidated or wild type 4E-BP2 in 4E-BP2−/
− neurons. Left: mEPSC traces from 4E-BP2−/− organotypic slices transfected with empty
vector (vec), wildtype 4E-BP2, or deamidated 4E-BP2 (N99D/N102D). Transfected cells were
identified by IRES-mediated eGFP expression from the same plasmid encoding 4E-BP2
variants. Right top: Cumulative probability plots of mEPSC amplitude, charge, and frequency.
Right bottom: Summary of effects on mEPSC amplitude, charge and frequency. (N=6 neurons/
condition and 150 events/neuron; * p < 0.05, ** p < 0.01. One-way ANOVA). (C) Partial
repression of mEPSC charge by deamidated 4E-BP2 is associated with slower kinetics. Top:
Individual (10 traces, grey) and averaged (150 events, black) mEPSCs from neurons transfected
as in (B). Superimposed scaled responses of average mEPSCs, are at the right. Bottom left:
Cumulative probability plots for 10-90% rise and 90-10% decay times for all groups (p < 0.05,
Kolmogorov-Smirnov test). Bottom right: Summary bar graphs of rise and decay times. (N=6,
p < 0.01. One-way ANOVA). See also Figure S6.
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